School of Medicine
Showing 12,121-12,140 of 13,039 Results
-
Erin Watson, PsyD, ABPP
Clinical Associate Professor, Medicine - Gastroenterology & Hepatology
BioErin Watson, PsyD, ABPP, is a board-certified clinical health psychologist and Clinical Associate Professor in the Division of Gastroenterology & Hepatology at Stanford University School of Medicine. She specializes in helping people understand and manage the psychological, behavioral, and lifestyle factors that can affect their physical health. Her clinical interests include coping with chronic illness, managing stress and health-related anxiety, making sustainable health behavior changes, and using evidence-based mind-body and behavioral approaches to improve symptoms, functioning, and quality of life.
Dr. Watson has specialized in health psychology and behavioral medicine throughout her education, training, and career. She completed her doctoral training with an emphasis in Primary Care Psychology and Behavioral Medicine, followed by advanced training in health psychology and integrated medical care and a postdoctoral fellowship focused on infectious and liver diseases. Before joining Stanford, she spent more than a decade at the San Francisco VA and UCSF providing behavioral health care within medical settings, including primary care, chronic pain, liver and infectious disease, bariatric medicine, and outpatient health psychology.
At Stanford, Dr. Watson is part of GI & Liver Behavioral Medicine, where she works with adults living with digestive and liver conditions. Her work in psychogastroenterology addresses the important connections between the brain, behavior, and digestive system. She also has a particular interest in advancing psycho-hepatology, which brings health psychology and behavioral medicine into liver care. Her goal is to help patients develop practical skills for coping with illness, managing symptoms and stress, changing health behaviors, and living well alongside chronic medical conditions.
Dr. Watson is a dedicated clinician-educator with more than a decade of experience teaching and supervising psychology trainees and educating healthcare professionals across disciplines. Her current academic work includes research examining behavioral approaches to chronic pain and opioid use through a National Institutes of Health-funded study, as well as a recently funded Patient-Centered Outcomes Research Institute (PCORI) study evaluating behavioral interventions for people living with rare liver diseases. Across her clinical care, research, teaching, and program development, she works to advance the integration of psychological and behavioral science into medical care and improve the health and quality of life of people living with chronic disease. -
Kathleen Watson
Clinical Assistant Professor, Psychiatry and Behavioral Sciences
BioKathleen Watson, Ph.D., currently serves as an instructor at Stanford University School of Medicine, specializing in Epidemiology and Clinical Research. She co-founded Microclinic International in 2007, where she served as Chief Operating Officer until 2012, focusing on socially-based health interventions for underserved communities.
Dr. Watson's research encompasses various aspects of mental health and metabolism. She investigates the connection between insulin resistance and depression, using computational psychiatry to uncover insights into the interplay of metabolic factors in mental well-being. Additionally, her exploration of cognitive aging examines how metabolic alterations might impact cognitive decline and related disorders. Furthermore, her research in proteomics aims to identify potential biomarkers for severe major depressive disorder. Dr. Watson has recently become a part of the Stanford Autism Center for Excellence Data Core, where she works under the guidance of Dr. Booil Jo. -
Robert Waymouth
Robert Eckles Swain Professor of Chemistry and Professor, by courtesy, of Chemical Engineering
BioRobert Eckles Swain Professor in Chemistry Robert Waymouth investigates new catalytic strategies to create useful new molecules, including bioactive polymers, synthetic fuels, and sustainable plastics. In one such breakthrough, Professor Waymouth and Professor Wender developed a new class of gene delivery agents.
Born in 1960 in Warner Robins, Georgia, Robert Waymouth studied chemistry and mathematics at Washington and Lee University in Lexington, Virginia (B.S. and B.A., respectively, both summa cum laude, 1982). He developed an interest in synthetic and mechanistic organometallic chemistry during his doctoral studies in chemistry at the California Institute of Technology under Professor R.H. Grubbs (Ph.D., 1987). His postdoctoral research with Professor Piero Pino at the Institut fur Polymere, ETH Zurich, Switzerland, focused on catalytic hydrogenation with chiral metallocene catalysts. He joined the Stanford University faculty as assistant professor in 1988, becoming full professor in 1997 and in 2000 the Robert Eckles Swain Professor of Chemistry.
Today, the Waymouth Group applies mechanistic principles to develop new concepts in catalysis, with particular focus on the development of organometallic and organic catalysts for the synthesis of complex macromolecular architectures. In organometallic catalysis, the group devised a highly selective alcohol oxidation catalyst that selectively oxidizes unprotected polyols and carbohydrates to alpha-hyroxyketones. In collaboration with Dr. James Hedrick of IBM, we have developed a platform of highly active organic catalysts and continuous flow reactors that provide access to polymer architectures that are difficult to access by conventional approaches.
The Waymouth group has devised selective organocatalytic strategies for the synthesis of functional degradable polymers and oligomers that function as "molecular transporters" to deliver genes, drugs and probes into cells and live animals. These advances led to the joint discovery with the Wender group of a general, safe, and remarkably effective concept for RNA delivery based on a new class of synthetic cationic materials, Charge-Altering Releasable Transporters (CARTs). This technology has been shown to be effective for mRNA based cancer vaccines. -
Annika M. Weber
Postdoctoral Scholar, Gastroenterology
BioAnnika is a postdoctoral scholar in the Spencer Lab studying how gut microbes metabolize prebiotic fibers to produce bioactive metabolites linked to lowering disease risk. She holds an MS in Human Nutrition from the University of Sheffield and a PhD in Food Science and Human Nutrition from Colorado State University. Her work integrates multi-omic approaches to map diet-microbe-metabolite relationships. Annika aims to translate these mechanistic insights into microbiome-informed dietary strategies for reducing chronic diseases.
-
Kenneth Weber, DC, PhD
Assistant Professor (Research) of Anesthesiology, Perioperative and Pain Medicine (Adult Pain) and, by courtesy, of Neurosurgery (Adult Neurosurgery) and of Radiology (Neuroimaging and Neurointervention)
BioDr. Weber directs the Neuromuscular Insight Lab. Dr. Weber's research seeks to develop quantitative markers of sensory and motor function, including pain, using machine-learning and advanced brain, spinal cord, and musculoskeletal magnetic resonance imaging. Dr. Weber aims to use these techniques to better understand the neuropathology of neurological and musculoskeletal conditions and discover more effective treatments and preventative strategies.
